LYEL - Lyell Immunopharma to Participate in Upcoming Investor Conferences | Benzinga

SOUTH SAN FRANCISCO, Calif., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (NASDAQ:LYEL), a clinical?stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors, today announced that members of its senior management team will participate in the following upcoming healthcare conferences:

• Morgan Stanley 21st Annual Global Healthcare Conference
  
  • Monday, September 11, 4:55 p.m. ET

• H.C. Wainwright 25th Annual Global Investment Conference
  
  • Tuesday, September 12^th, 9:00 a.m. ET

• 2023 Cantor Global Healthcare Conference
  
  • Wednesday, September 27^th at 3:35 ...

Full story available on Benzinga.com